S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
NASDAQ:GAN

GAN Competitors

$27.45
+0.53 (+1.97 %)
(As of 02/24/2021 05:00 PM ET)
Add
Compare
Today's Range
$25.89
Now: $27.45
$27.55
50-Day Range
$19.92
MA: $25.56
$30.53
52-Week Range
$10.60
Now: $27.45
$31.81
Volume603,339 shs
Average Volume1.54 million shs
Market Capitalization$1.01 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

GAN (NASDAQ:GAN) Vs. CDLX, YALA, PS, SVMK, HCAT, and EB

Should you be buying GAN stock or one of its competitors? Companies in the industry of "computer programming, data processing, & other computer related" are considered alternatives and competitors to GAN, including Cardlytics (CDLX), Yalla Group (YALA), Pluralsight (PS), SVMK (SVMK), Health Catalyst (HCAT), and Eventbrite (EB).

Cardlytics (NASDAQ:CDLX) and GAN (NASDAQ:GAN) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, dividends and profitability.

Institutional and Insider Ownership

97.0% of Cardlytics shares are held by institutional investors. Comparatively, 26.1% of GAN shares are held by institutional investors. 6.5% of Cardlytics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Cardlytics and GAN's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardlytics$210.43 million18.27$-17,140,000.00($0.75)-186.61
GAN$29.97 million33.55$1.79 millionN/AN/A

GAN has lower revenue, but higher earnings than Cardlytics.

Analyst Ratings

This is a summary of recent recommendations for Cardlytics and GAN, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cardlytics13202.17
GAN00403.00

Cardlytics currently has a consensus price target of $77.1667, indicating a potential downside of 44.93%. GAN has a consensus price target of $29.25, indicating a potential upside of 6.56%. Given GAN's stronger consensus rating and higher probable upside, analysts plainly believe GAN is more favorable than Cardlytics.

Profitability

This table compares Cardlytics and GAN's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cardlytics-23.91%-31.98%-17.94%
GAN-24.35%0.61%0.46%

Summary

GAN beats Cardlytics on 7 of the 11 factors compared between the two stocks.

Yalla Group (NYSE:YALA) and GAN (NASDAQ:GAN) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Analyst Ratings

This is a summary of recent recommendations and price targets for Yalla Group and GAN, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Yalla Group02002.00
GAN00403.00

GAN has a consensus target price of $29.25, suggesting a potential upside of 6.56%. Given GAN's stronger consensus rating and higher probable upside, analysts plainly believe GAN is more favorable than Yalla Group.

Valuation and Earnings

This table compares Yalla Group and GAN's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yalla GroupN/AN/AN/AN/AN/A
GAN$29.97 million33.55$1.79 millionN/AN/A

GAN has higher revenue and earnings than Yalla Group.

Profitability

This table compares Yalla Group and GAN's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Yalla GroupN/AN/AN/A
GAN-24.35%0.61%0.46%

Insider and Institutional Ownership

26.1% of GAN shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

GAN beats Yalla Group on 7 of the 8 factors compared between the two stocks.

Pluralsight (NASDAQ:PS) and GAN (NASDAQ:GAN) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

Valuation and Earnings

This table compares Pluralsight and GAN's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pluralsight$316.91 million9.65$-112,660,000.00($0.98)-21.43
GAN$29.97 million33.55$1.79 millionN/AN/A

GAN has lower revenue, but higher earnings than Pluralsight.

Profitability

This table compares Pluralsight and GAN's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pluralsight-33.16%-57.42%-12.33%
GAN-24.35%0.61%0.46%

Analyst Ratings

This is a breakdown of recent ratings and price targets for Pluralsight and GAN, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pluralsight114302.11
GAN00403.00

Pluralsight presently has a consensus target price of $21.23, indicating a potential upside of 1.05%. GAN has a consensus target price of $29.25, indicating a potential upside of 6.56%. Given GAN's stronger consensus rating and higher possible upside, analysts plainly believe GAN is more favorable than Pluralsight.

Institutional and Insider Ownership

80.5% of Pluralsight shares are owned by institutional investors. Comparatively, 26.1% of GAN shares are owned by institutional investors. 21.8% of Pluralsight shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

GAN beats Pluralsight on 8 of the 11 factors compared between the two stocks.

SVMK (NASDAQ:SVMK) and GAN (NASDAQ:GAN) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, earnings and valuation.

Insider & Institutional Ownership

77.5% of SVMK shares are owned by institutional investors. Comparatively, 26.1% of GAN shares are owned by institutional investors. 18.7% of SVMK shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for SVMK and GAN, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
SVMK02502.71
GAN00403.00

SVMK presently has a consensus price target of $27.5714, indicating a potential upside of 39.96%. GAN has a consensus price target of $29.25, indicating a potential upside of 6.56%. Given SVMK's higher possible upside, equities analysts clearly believe SVMK is more favorable than GAN.

Profitability

This table compares SVMK and GAN's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SVMK-26.35%-29.97%-11.44%
GAN-24.35%0.61%0.46%

Earnings & Valuation

This table compares SVMK and GAN's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SVMK$307.42 million9.23$-73,860,000.00($0.56)-35.13
GAN$29.97 million33.55$1.79 millionN/AN/A

GAN has lower revenue, but higher earnings than SVMK.

Summary

GAN beats SVMK on 6 of the 11 factors compared between the two stocks.

GAN (NASDAQ:GAN) and Health Catalyst (NASDAQ:HCAT) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, profitability and institutional ownership.

Analyst Recommendations

This is a summary of current recommendations for GAN and Health Catalyst, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
GAN00403.00
Health Catalyst00913.10

GAN currently has a consensus price target of $29.25, indicating a potential upside of 6.56%. Health Catalyst has a consensus price target of $42.5385, indicating a potential downside of 11.69%. Given GAN's higher possible upside, equities analysts plainly believe GAN is more favorable than Health Catalyst.

Earnings and Valuation

This table compares GAN and Health Catalyst's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GAN$29.97 million33.55$1.79 millionN/AN/A
Health Catalyst$154.94 million13.22$-60,100,000.00($1.42)-33.94

GAN has higher earnings, but lower revenue than Health Catalyst.

Profitability

This table compares GAN and Health Catalyst's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GAN-24.35%0.61%0.46%
Health Catalyst-48.17%-25.57%-14.56%

Institutional and Insider Ownership

26.1% of GAN shares are owned by institutional investors. Comparatively, 94.2% of Health Catalyst shares are owned by institutional investors. 22.1% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

GAN (NASDAQ:GAN) and Eventbrite (NYSE:EB) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, risk, earnings, analyst recommendations and profitability.

Insider & Institutional Ownership

26.1% of GAN shares are held by institutional investors. Comparatively, 67.2% of Eventbrite shares are held by institutional investors. 16.8% of Eventbrite shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares GAN and Eventbrite's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GAN$29.97 million33.55$1.79 millionN/AN/A
Eventbrite$326.80 million5.86$-68,760,000.00($0.84)-24.86

GAN has higher earnings, but lower revenue than Eventbrite.

Profitability

This table compares GAN and Eventbrite's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GAN-24.35%0.61%0.46%
Eventbrite-134.78%-63.75%-27.38%

Analyst Ratings

This is a breakdown of current ratings and recommmendations for GAN and Eventbrite, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
GAN00403.00
Eventbrite03202.40

GAN currently has a consensus price target of $29.25, suggesting a potential upside of 6.56%. Eventbrite has a consensus price target of $12.80, suggesting a potential downside of 38.70%. Given GAN's stronger consensus rating and higher probable upside, research analysts clearly believe GAN is more favorable than Eventbrite.

Summary

GAN beats Eventbrite on 8 of the 11 factors compared between the two stocks.


GAN Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Cardlytics logo
CDLX
Cardlytics
1.1$139.96+0.9%$3.81 billion$210.43 million-83.31Upcoming Earnings
YALA
Yalla Group
0.2$25.50+3.5%$3.78 billionN/A0.00Upcoming Earnings
Gap Down
Pluralsight logo
PS
Pluralsight
1.2$21.00+0.4%$3.05 billion$316.91 million-19.27
SVMK logo
SVMK
SVMK
1.6$19.67+1.9%$2.78 billion$307.42 million-28.10
HCAT
Health Catalyst
1.4$48.19+0.8%$2.05 billion$154.94 million-21.42Upcoming Earnings
Eventbrite logo
EB
Eventbrite
1.1$20.88+2.3%$1.91 billion$326.80 million-8.29Upcoming Earnings
Model N logo
MODN
Model N
1.2$45.09+4.5%$1.51 billion$161.06 million-109.98
EVER
EverQuote
1.8$51.82+4.0%$1.38 billion$248.81 million-167.16Earnings Announcement
Analyst Report
Analyst Revision
News Coverage
QTT
Qutoutiao
0.5$3.81+4.2%$1.12 billion$790.85 million-4.59
HealthStream logo
HSTM
HealthStream
1.2$23.77+1.7%$740.00 million$254.11 million45.71Earnings Announcement
Analyst Report
Analyst Revision
News Coverage
JG
Aurora Mobile
0.5$6.04+3.1%$721.28 million$130.21 million-28.76
Sify Technologies logo
SIFY
Sify Technologies
1.2$3.38+0.9%$600.40 million$326.31 million0.00
TrueCar logo
TRUE
TrueCar
1.0$5.06+1.4%$519.43 million$353.88 million-29.76News Coverage
LIZI
Lizhi
1.1$10.06+0.2%$460.99 million$169.58 million-9.96
ESSC
East Stone Acquisition
0.2$10.02+0.2%$177.74 millionN/A0.00
ALYA
Alithya Group
0.6$2.34+5.6%$112.87 million$210.26 million-3.97News Coverage
Gap Down
CNET
ZW Data Action Technologies
0.5$3.60+6.7%$87.57 million$58.08 million-21.18Gap Down
Synacor logo
SYNC
Synacor
0.7$2.17+0.5%$85.63 million$121.85 million-7.23Upcoming Earnings
PT
Pintec Technology
0.5$1.75+10.9%$67.19 million$184.61 million0.00Gap Up
Jianpu Technology logo
JT
Jianpu Technology
1.0$2.85+2.1%$58.91 million$234.18 million-1.19
MOXC
Moxian
0.3$2.59+6.2%$39.34 million$370,000.000.00
GIGM
GigaMedia
0.6$3.60+4.4%$38.02 million$6.64 million-36.00News Coverage
AutoWeb logo
AUTO
AutoWeb
1.5$2.83+2.1%$37.27 million$113.98 million-4.16
Professional Diversity Network logo
IPDN
Professional Diversity Network
0.4$2.99+3.0%$37.18 million$5.03 million0.00Upcoming Earnings
Gap Down
OBLG
Oblong
1.0$4.93+7.5%$35.34 million$12.83 million0.00
This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.